Friends of FSH Research manages a portfolio of grants to accelerate discoveries for FSHD. To do this, we leverage the expertise of our world-class scientific advisory board and our scientific development director.
Learn more about how we review our science, and maintain an active an collaborative culture to ensure robust and reproducible findings.
Dr. Miller is a Professor at the University of Washington in Seattle.
Dr. Block is VP Business Development at Universal Cells in Seattle.
Dr. Kennedy is President and CEO of the Buck Institute for Research on Aging in Novato California.
Dr. Chamberlain, a neurologist with expertise in the muscular dystrophies, received a Ph.D. from the University of Washington. His research focuses on understanding and developing treatments for the muscular dystrophies and other muscular disorders.
Dr. Yokomori is a Professor, Biological Chemistry School of Medicine.
Dr. Wentworth is the VP of Discovery Research at Sarapta Therapeutics.
Dr. Shaw is Division Chief of MRI and Vascular/Interventional Imaging at Seattle Children's Hospital.